Biotime-Nasdaq's best kept secret? | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotime-Nasdaq's best kept secret?

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
1432	16	0	BTIM

Emcee: William Nguyen	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
407	Sorry Jim for calling you Mark. Thanks for your insight. It is intersting tha	Nick Takos	-	10/31/1997
406	I am obviously not Mark but here are two observations that I have. One, Abbo	Jim Roof	-	10/31/1997
405	Mark, Why do you assume Hextend will take over 50% of the market ? I have no	Nick Takos	-	10/31/1997
404	Todd: It was easy to miss, buried in that Appendix way in the back of the Agre	Mark A. Voelker	-	10/30/1997
403	Todd: For your convenience, here is the entire text of Appendix D of the "	Mark A. Voelker	-	10/30/1997
402	Mark- You are absolutely right. I'm surprised that I missed that. Anyway, I	Todd D. Wiener	-	10/30/1997
401	Hi Todd: Thanks for the response, but I stand by my statement. Yes, the royalt	Mark A. Voelker	-	10/30/1997
400	Here's the Form 144 that was filed tonite: Issuers Name	Todd D. Wiener	-	10/30/1997
399	Thanks for your insight. There have been conlicting opinions on the "REAL	Nick Takos	-	10/30/1997
398	The Abbott deal is exclusive to the US. The market for blood volume expanders	Jim Roof	-	10/30/1997
397	Actually, I can read the royalty paragraph from your post either way with no di	Jim Roof	-	10/30/1997
396	New this thread, sorry if this was mentioned in an earlier post.. Does Abott h	Nick Takos	-	10/30/1997
395	Mark- I appreciate your response, but I believe that you are mistaken. Accordi	Todd D. Wiener	-	10/30/1997
394	I think the way BTIM responded after getting hammered to 55 in a screwy market	Jim Roof	-	10/30/1997
393	Todd: The 36% maximum royalty rate in the Abbot Labs agreement is applied to t	Mark A. Voelker	-	10/30/1997
392	Todd, I guess I'll have to be happy with $30/share earnings. Saul	Saul H Rosenthal	-	10/30/1997
391	George- It doesn't look as if BTIM's going to drop much lower, so if y	Todd D. Wiener	-	10/30/1997
390	At this price level is it still a good time to jump in?	george johnson	-	10/30/1997
389	Todd, Thanks for your financial analysis. It was extremely enlightening. Its	Glenn MacDonald	-	10/29/1997
388	Saul- Let's assume that Hextend sales in 5 years are $500 million. BTIM wo	Todd D. Wiener	-	10/29/1997
387	Todd, How do you figure a 60% net margin! They have no manufacturing costs. N	Saul H Rosenthal	-	10/29/1997
386	Today we are up 7 right now, been up 11!!! What a comeback. People definitely a	David Rangel	-	10/29/1997
385	David- I included taxes. BTIM is projected to have a 60% net margin. That mean	Todd D. Wiener	-	10/29/1997
384	I know this stock is not earnings driven at this point , but does anyone know e	Joe F.	-	10/29/1997
383	Don't forget about taxes. that'll reduce the # by 1/3. <I agree wit	Lazlo Pierce	-	10/29/1997

Go to reply# or date (mm/dd/yy):